BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-02-17

Reporting Person: Ho Maykin (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-17	Common Stock	A	2350	—	Acquired	2350	Direct

Footnotes

F1: Restricted stock units granted on February 17, 2021 represent a pro rata share of the 2020 annual award for independent directors and vest on the date immediately prior to the date of the Company's next regular annual meeting of stockholders, the same vesting date for the 2020 annual award for all other independent directors.